- Home
- DOCN vs PODD Comparison
DOCN vs PODD Comparison
Compare DOCN & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DOCN | PODD |
|---|---|---|
| Founded | 2011 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.2B | 10.3B |
| IPO Year | 2021 | 2007 |
Fundamental Metrics
Financial Performance| Metric | DOCN | PODD |
|---|---|---|
| Price | $109.67 | $150.45 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 21 |
| Target Price | $85.46 | ★ $341.48 |
| AVG Volume (30 Days) | ★ 2.1M | 1.9M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 183.15 | N/A |
| EPS | 0.45 | ★ 2.67 |
| Revenue | $901,427,000.00 | ★ $2,708,100,000.00 |
| Revenue This Year | $23.80 | $24.55 |
| Revenue Next Year | $30.11 | $19.18 |
| P/E Ratio | $233.00 | ★ $55.47 |
| Revenue Growth | 15.48 | ★ 30.73 |
| 52 Week Low | $32.35 | $126.40 |
| 52 Week High | $187.50 | $354.88 |
Technical Indicators
Market Signals| Indicator | DOCN | PODD |
|---|---|---|
| Relative Strength Index (RSI) | 43.38 | 50.24 |
| Support Level | $108.53 | $139.67 |
| Resistance Level | $140.15 | $155.17 |
| Average True Range (ATR) | 7.48 | 5.27 |
| MACD | -0.73 | 0.91 |
| Stochastic Oscillator | 24.73 | 65.02 |
Price Performance
Historical ComparisonAbout DOCN DigitalOcean Holdings Inc.
DigitalOcean Holdings Inc is a cloud computing platform offering on-demand infrastructure and platform tools for developers, start-ups, and small and medium-sized businesses. The customers use the platform for a wide range of cases, such as web and mobile applications, website hosting, e-commerce, media and gaming, personal web projects, and managed services, among many others. Geographically, the company generates maximum revenue from North America and also has a presence in Europe, Asia, and the Rest of the world.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.